GlassScriptPhysician profile
William N Dixon
NPI 1427262591
$550.45
in general payments reported to CMS, 2019-2025
14 companies · $247 in 2025
The $247 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.28 · 2020: $52.04 · 2021: $30.13 · 2024: $182 · 2025: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $429.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $121.61 | 2024-2025 | |
| Davol INC. | $90.23 | 2024-2025 | Phasix Mesh |
| Intuitive Surgical, INC. | $64.42 | 2025 | |
| Kerecis Limited | $49.84 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $43.31 | 2019-2024 | Pico 14 |
| Abbvie INC. | $40.42 | 2024-2025 | |
| Innovation Technologies INC | $26.04 | 2025 | Irrisept |
| W. L. Gore & Associates, INC. | $22.71 | 2020 | |
| Baudax Bio INC. | $17.95 | 2020 | |
| Paratek Pharmaceuticals, INC. | $15.93 | 2024 | Nuzyra |
| Kci USA, INC. | $15.42 | 2019 | |
| Mallinckrodt Hospital Products INC. | $15.10 | 2021 | |
| Innocoll Pharmaceuticals Limited | $15.03 | 2021 | |
| Lemaitre Vascular, INC. | $12.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Dixon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.